Lapsed Nov 12, 2025 on the fee record · Medium confidence
20-year base term ended May 28, 2023
Why Medium: A terminal disclaimer is on file (approved) with no resolved reference, so the term may end earlier.
Third maintenance fee unpaid; grace period ended.
May 28, 2003
Nov 12, 2025
Nov 12, 2013
Sep 16, 2027
Its term would have run to Sep 16, 2027: its 20-year base term plus 1572 days of term adjustment for prosecution delay. A terminal disclaimer is on file with no resolved reference, so no cap is applied and none is guessed. Confidence: Medium. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts May 28, 2003, when application 10/446,562, the earliest non-provisional in its chain, was filed (this one was filed Feb 22, 2007) | May 28, 2023 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +1572 days, USPTO patent term adjustment record | Sep 16, 2027 | High confidence |
| Terminal disclaimer cap | Disclaimer on file (approved), reference document not resolved | no cap applied, and none guessed | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 3 maintenance fees paid | lapsed Nov 12, 2025 | High confidence |
| Computed term end | The steps above, in order | Nov 12, 2025 | Medium confidence |
This family
| US 7,459,164 | Term ended Jul 2025 | Jul 2025 |
| US 7,491,403 | Term ended no later than Dec 2023 | no later than Dec 2023 |
| US 7,691,394 | Term ended May 2023 | May 2023 |
| Application PCT/US2006/015459 | PCT application no patent term | no patent term |
| US 8,580,745 | this patent Nov 2025 | Nov 2025 |
| US 8,241,640 | In force Jan 2027 | Jan 2027 |
| US 8,679,486 | Term ended May 2023 | May 2023 |
| Application 14/225,011 | Abandoned not computed | not computed |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Apr 4, 2007 Reel 19120, frame 136 | Borodic, Gary E. | Botulinum Toxin Research Associates Inc. | Assignment of Assignor's Interest |
| Jun 3, 2016 Reel 38870, frame 160 | Botulinum Toxin Research Associates, Inc. | Revance Therapeutics, Inc. | Assignment of Assignor's Interest |
| Mar 18, 2022 Reel 59437, frame 654 | Revance Therapeutics, Inc. | Athyrium Buffalo LP | Security Interest |
| Feb 7, 2025 Reel 70153, frame 630 | Athyrium Buffalo LP | Revance Therapeutics, Inc. | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer is on file (approved) and its reference document is not resolved. A disclaimer would cap the term earlier than Nov 12, 2025. We will not guess the cap.